Cargando…

Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer

Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United States. A well recognized disparity by race in both incidence and survival outcome exists for this cancer. Specifically Caucasians are about two times more likely to develop endometrial cancer than are African-Ame...

Descripción completa

Detalles Bibliográficos
Autores principales: Allard, Jay E., Chandramouli, Gadisetti V. R., Stagliano, Katherine, Hood, Brian L., Litzi, Tracy, Shoji, Yutaka, Boyd, Jeff, Berchuck, Andrew, Conrads, Thomas P., Maxwell, G. Larry, Risinger, John I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389395/
https://www.ncbi.nlm.nih.gov/pubmed/22783543
http://dx.doi.org/10.3389/fonc.2012.00065
_version_ 1782237303548149760
author Allard, Jay E.
Chandramouli, Gadisetti V. R.
Stagliano, Katherine
Hood, Brian L.
Litzi, Tracy
Shoji, Yutaka
Boyd, Jeff
Berchuck, Andrew
Conrads, Thomas P.
Maxwell, G. Larry
Risinger, John I.
author_facet Allard, Jay E.
Chandramouli, Gadisetti V. R.
Stagliano, Katherine
Hood, Brian L.
Litzi, Tracy
Shoji, Yutaka
Boyd, Jeff
Berchuck, Andrew
Conrads, Thomas P.
Maxwell, G. Larry
Risinger, John I.
author_sort Allard, Jay E.
collection PubMed
description Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United States. A well recognized disparity by race in both incidence and survival outcome exists for this cancer. Specifically Caucasians are about two times more likely to develop endometrial cancer than are African-Americans. However, African-American women are more likely to die from this disease than are Caucasians. The basis for this disparity remains unknown. Previous studies have identified differences in the types and frequencies of gene mutations among endometrial cancers from Caucasians and African-Americans suggesting that the tumors from these two groups might have differing underlying genetic defects. We performed a gene expression microarray study in an effort to identify differentially expressed transcripts between African-American and Caucasian women’s endometrial cancers. Our gene expression screen identified a list of potential biomarkers that are differentially expressed between these two groups of cancers. Of these we identified a poorly characterized transcript with a region of homology to phospho serine phosphatase (PSPH) and designated phospho serine phosphatase like (PSPHL) as the most differentially over-expressed gene in cancers from African-Americans. We further clarified the nature of expressed transcripts. Northern blot analysis confirmed the message was limited to a transcript of under 1 kB. Sequence analysis of transcripts confirmed two alternate open reading frame (ORF) isoforms due to alternative splicing events. Splice specific primer sets confirmed both isoforms were differentially expressed in tissues from Caucasians and African-Americans. We further examined the expression in other tissues from women to include normal endometrium, normal and malignant ovary. In all cases PSPHL expression was more often present in tissues from African-Americans than Caucasians. Our data confirm the African-American based expression of the PSPHL transcript in endometrial cancer and also identify its expression in other tissues from African-Americans including ovary and ovarian cancer. PSPHL represents a candidate gene that might influence the observed racial disparity in endometrial and other cancers.
format Online
Article
Text
id pubmed-3389395
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33893952012-07-10 Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer Allard, Jay E. Chandramouli, Gadisetti V. R. Stagliano, Katherine Hood, Brian L. Litzi, Tracy Shoji, Yutaka Boyd, Jeff Berchuck, Andrew Conrads, Thomas P. Maxwell, G. Larry Risinger, John I. Front Oncol Oncology Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United States. A well recognized disparity by race in both incidence and survival outcome exists for this cancer. Specifically Caucasians are about two times more likely to develop endometrial cancer than are African-Americans. However, African-American women are more likely to die from this disease than are Caucasians. The basis for this disparity remains unknown. Previous studies have identified differences in the types and frequencies of gene mutations among endometrial cancers from Caucasians and African-Americans suggesting that the tumors from these two groups might have differing underlying genetic defects. We performed a gene expression microarray study in an effort to identify differentially expressed transcripts between African-American and Caucasian women’s endometrial cancers. Our gene expression screen identified a list of potential biomarkers that are differentially expressed between these two groups of cancers. Of these we identified a poorly characterized transcript with a region of homology to phospho serine phosphatase (PSPH) and designated phospho serine phosphatase like (PSPHL) as the most differentially over-expressed gene in cancers from African-Americans. We further clarified the nature of expressed transcripts. Northern blot analysis confirmed the message was limited to a transcript of under 1 kB. Sequence analysis of transcripts confirmed two alternate open reading frame (ORF) isoforms due to alternative splicing events. Splice specific primer sets confirmed both isoforms were differentially expressed in tissues from Caucasians and African-Americans. We further examined the expression in other tissues from women to include normal endometrium, normal and malignant ovary. In all cases PSPHL expression was more often present in tissues from African-Americans than Caucasians. Our data confirm the African-American based expression of the PSPHL transcript in endometrial cancer and also identify its expression in other tissues from African-Americans including ovary and ovarian cancer. PSPHL represents a candidate gene that might influence the observed racial disparity in endometrial and other cancers. Frontiers Research Foundation 2012-07-04 /pmc/articles/PMC3389395/ /pubmed/22783543 http://dx.doi.org/10.3389/fonc.2012.00065 Text en Copyright © 2012 Allard, Chandramouli, Stagliano, Hood, Litzi, Shoji, Boyd, Berchuck, Conrads, Maxwell and Risinger. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Oncology
Allard, Jay E.
Chandramouli, Gadisetti V. R.
Stagliano, Katherine
Hood, Brian L.
Litzi, Tracy
Shoji, Yutaka
Boyd, Jeff
Berchuck, Andrew
Conrads, Thomas P.
Maxwell, G. Larry
Risinger, John I.
Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title_full Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title_fullStr Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title_full_unstemmed Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title_short Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer
title_sort analysis of psphl as a candidate gene influencing the racial disparity in endometrial cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389395/
https://www.ncbi.nlm.nih.gov/pubmed/22783543
http://dx.doi.org/10.3389/fonc.2012.00065
work_keys_str_mv AT allardjaye analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT chandramouligadisettivr analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT staglianokatherine analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT hoodbrianl analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT litzitracy analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT shojiyutaka analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT boydjeff analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT berchuckandrew analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT conradsthomasp analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT maxwellglarry analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer
AT risingerjohni analysisofpsphlasacandidategeneinfluencingtheracialdisparityinendometrialcancer